New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - clindamycin hydrochloride 177.515mg equivalent to 150 mg clindamycin - capsule - 150 mg - active: clindamycin hydrochloride 177.515mg equivalent to 150 mg clindamycin excipient: erythrosine gelatin indigo carmine lactose monohydrate magnesium stearate maize starch opacode white s-1-18086 purified talc titanium dioxide - upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever. lower respiratory infections including bronchitis, pneumonia, empyema and lung abscess.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (nz) ltd t/a mercury pharma (nz) - cyclophosphamide monohydrate 53.5mg equivalent to 50 mg cyclophosphamide - film coated tablet - 50 mg - active: cyclophosphamide monohydrate 53.5mg equivalent to 50 mg cyclophosphamide excipient: croscarmellose sodium isopropyl alcohol lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 21f240000 purified water - cyclophosphamide is a cytotoxic drug for the treatment of malignant disease in adults and children. as a single agent, it has successfully produced an objective remission in a wide range of malignant conditions. cyclophosphamide is also frequently used in combination with other cytotoxic drugs, radiotherapy or surgery

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - phenoxybenzamine hydrochloride 10mg - capsule - 10 mg - active: phenoxybenzamine hydrochloride 10mg excipient: erythrosine gelatin indigo carmine ink lactose monohydrate purified talc titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (nz) ltd t/a mercury pharma (nz) - aspirin 650mg (equal parts crystalline & granular);  ;   - enteric coated tablet - 650 mg - active: aspirin 650mg (equal parts crystalline & granular)     excipient: carnauba wax cellacefate diethyl phthalate guar gum quinoline yellow sunset yellow fcf titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - flecainide acetate 100mg;   - tablet - 100 mg - active: flecainide acetate 100mg   excipient: croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose pregelatinised maize starch purified water - in patients without structural heart disease and without myocardial infarction, flecainide bnm tablets are indicated for the prevention of: supraventricular arrhythmias · paroxysmal supraventricular tachycardias (psvt) including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms; · paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms. ventricular arrhythmias · documented life-threatening ventricular arrhythmias such as sustained ventricular tachycardia (vt) if they are considered life-threatening in the judgement of the attending physician. not indicated for less severe ventricular arrhythmias even if symptomatic. use of flecainide in chronic atrial fibrillation has not been adequately studied and is not recommended.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - hydroxocobalamin acetate 1 mg/ml - solution for injection - 1 mg/ml - active: hydroxocobalamin acetate 1 mg/ml excipient: acetic acid sodium acetate sodium chloride water for injection - addisonian pernicious anaemia. prophylaxis and treatment of other macrocytic anaemias associated with vitamin b12 deficiency. tobacco amblyopia and leber's optic atrophy.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - coal tar solution 4.25%{relative} (81-86% ethanol); salicylic acid 2%{relative};  ;  ;   - shampoo - active: coal tar solution 4.25%{relative} (81-86% ethanol) salicylic acid 2%{relative}       excipient: benzalkonium chloride ethanol lauromacrogol 1150 lauromacrogol 200 purified water sodium edetate

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - methadone hydrochloride 10 mg/ml - oral solution - 10 mg/ml - active: methadone hydrochloride 10 mg/ml excipient: brilliant blue fcf cherry flavour it1037 citric acid monohydrate glycerol hyetellose purified water sodium benzoate xylitol - indicated in detoxification and maintenance treatment as a substitute for heroin or other morphine-like drugs to suppress the opiate-agonist abstinence syndrome in patients who are dependent on these drugs.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - methadone hydrochloride 1 mg/ml - oral solution - 1 mg/ml - active: methadone hydrochloride 1 mg/ml excipient: brilliant blue fcf cherry flavour it1037 citric acid monohydrate glycerol hyetellose purified water sodium benzoate tartrazine xylitol - indicated in detoxification and maintenance treatment as a substitute for heroin or other morphine-like drugs to suppress the opiate-agonist abstinence syndrome in patients who are dependent on these drugs.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - methadone hydrochloride 5 mg/ml - oral solution - 5 mg/ml - active: methadone hydrochloride 5 mg/ml excipient: caramel cherry flavour it1037 citric acid monohydrate glycerol hyetellose purified water sodium benzoate xylitol - indicated in detoxification and maintenance treatment as a substitute for heroin or other morphine-like drugs to suppress the opiate-agonist abstinence syndrome in patients who are dependent on these drugs.